TikTok is buzzing about beetroot juice as a natural remedy for fatty liver and weight loss. While beetroots offer numerous health benefits, including detoxifying the liver and promoting weight loss, it’s crucial to consult a healthcare professional before embarking on any juice cleanse, especially if you’re prone to kidney stones.
Attorneys representing patients of an Oregon hospital have filed a $303 million lawsuit alleging that a nurse replaced prescribed fentanyl with tap water, leading to infections and deaths. The lawsuit accuses the hospital of negligence for failing to prevent drug diversion by employees.
As a dangerous heat wave grips Southern California, hospitals brace for a surge in heat-related illnesses. Experts advise staying hydrated, avoiding strenuous activity during the hottest hours, and wearing light clothing. This article provides tips on staying safe and healthy during the extreme temperatures.
The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved Moderna’s updated COVID-19 vaccine targeting the Omicron variant. The vaccine will be available through the NHS autumn vaccination program and privately for those not eligible. This follows similar approvals in Taiwan and the US for updated COVID-19 vaccines.
Valneva and Pfizer announced positive immunogenicity and safety data from their Phase 2 study of a second booster dose for their Lyme disease vaccine candidate, VLA15. The data shows a robust immune response and a favorable safety profile, with the second booster providing similar benefits to the first. The companies are currently conducting two Phase 3 trials with the goal of submitting marketing applications to the FDA and EMA in 2026.
SOMAÍ Pharmaceuticals, a Portugal-based marijuana company, has partnered with Cosma S.A., a Polish company focused on cannabis-based pharmaceutical advancements, to introduce a range of advanced cannabis-based products to Polish patients. The partnership aims to improve access to high-quality, innovative cannabis-based therapies for Polish patients, with Cosma S.A. acting as the marketing authorization holder (MAH) for both companies’ products.
Dyne Therapeutics announced positive clinical data from its Phase 1/2 DELIVER trial of DYNE-251 for Duchenne muscular dystrophy (DMD). The drug showed significant dystrophin expression and functional improvements in patients, exceeding levels observed in other DMD treatments. Dyne plans to initiate registrational cohorts in the trial and provide an update on the path to registration by the end of 2024.
Praxis Precision Medicines announced positive topline results from its EMBOLD Phase 2 study evaluating relutrigine in patients with SCN2A and SCN8A developmental and epileptic encephalopathy (DEE). The study showed a significant reduction in seizures, improvements in behavior and communication, and a favorable safety profile.
A hospice nurse shares her insights on the dying process, breaking down the stages into understandable steps to help families understand what to expect and reduce fear. This guide provides a realistic perspective on death, dispelling common misconceptions perpetuated by media and offering clarity for loved ones during a difficult time.
The World Health Organization (WHO) has reported exceeding its vaccination targets in Gaza during a mass campaign aimed at stemming a recent polio outbreak. This achievement comes amidst ongoing conflict, with daily ceasefires facilitating the vaccination efforts.
